Role of VIP/PACAP in primary headaches

Cephalalgia

Volumn 33, Issue 13, 2013, Pages 1070-1072

  Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PHOSPHOLIPASE D;

BACKACHE; BLOOD VESSEL; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MIGRAINE; PARASYMPATHETIC NERVE; PRIMARY HEADACHE; REVIEW;

FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE;

EID: 84884194414     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413483929     Document Type: Review

References (26)

1. Tuka B, Helyes Z, Markovics A, et al. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia. 2013 ; 33 :
2. Schytz HW, Birk S, Wienecke T, et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 2009 ; 132: 16-25
3. Amin FM, Asghar MS, Guo S, et al. Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. Cephalalgia. 2012 ; 32: 140-149
4. Olesen J, Burstein R, Ashina M, et al. Origin of pain in migraine: Evidence for peripheral sensitisation. Lancet Neurol. 2009 ; 8: 679-690
5. Rahmann A, Wienecke T, Hansen JM, et al. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 2008 ; 28: 226-236
6. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Rev. 2005 ; 48: 438-456
7. Edvinsson L, Villalón CM, MaassenVanDenBrink A. Basic mechanisms of migraine and its acute treatment. Pharmacol Ther. 2012 ; 136: 319-333
8. Said SI, Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature. 1970 ; 28: 863-864
9. Miyata A, Arimura A, Dahl RR, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 1989 ; 164: 567-574
10. Fahrenkrug J. PACAP - a multifaceted neuropeptide. Chronobiol Int. 2006 ; 23: 53-61
11. Fahrenkrug J, Hannibal J. Neurotransmitters co-existing with VIP or PACAP. Peptides. 2004 ; 25: 393-401
12. Dickson L, Finlayson K. VPAC and PAC receptors: From ligands to function. Pharmacol Ther. 2009 ; 121: 294-316
13. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993 ; 33: 48-56
14. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 1994 ; 117: 427-434
15. Csati A, Tajti J, Tuka B, et al. Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion - interaction with the sensory system. Brain Res. 2012 ; 1435: 29-39
16. Edvinsson L, Hara H, Uddman R. Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: Colocalization with different peptides. J Cereb Blood Flow Metab. 1989 ; 9: 212-218
17. Edvinsson L, Elsås T, Suzuki N, et al. Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. Microsc Res Tech. 2001 ; 53: 221-228
18. Tajti J, Uddman R, Möller S, et al. Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst. 1999 ; 76: 176-183
19. Christiansen T, Bruun A, Knight YE, et al. Immunoreactivity of NOS, CGRP, PACAP, SP and VIP in the trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 of the cat. J Headache Pain. 2003 ; 4: 156-163
20. Lorén I, Emson PC, Fahrenkrug J, et al. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience. 1979 ; 4: 1953-1976
21. Grände G, Nilsson E, Edvinsson L. Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method. Cephalalgia. 2013 ; 33: 152-159
22. Baun M, Hay-Schmidt A, Edvinsson L, et al. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat. Eur J Pharmacol. 2011 ; 670: 186-194
23. Boni LJ, Ploug KB, Olesen J, et al. The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery. Cephalalgia. 2009 ; 29: 837-847
24. Knutsson M, Edvinsson L. Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. Neuroreport. 2002 ; 13: 507-509
25. Chan KY, Baun M, de Vries R, et al. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia. 2011 ; 31: 181-189
26. Baun M, Pedersen MHF, Olesen J, et al. Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia. 2012 ; 32: 337-345